Clinical Observation on the Treatment of Acute Tinnitus with Retroauricular Injection of Methylprednisolone

Abstract

Objective: To explore and analyze the clinical effect of retroauricular injection of methylprednisolone in the treatment of acute tinnitus patients. Method: 100 acute tinnitus patients treated in Shaanxi Provincial People’s Hospital from March 2021 to March 2022 were selected as the research subjects. After obtaining the consent of the patient and their family, a random allocation method is used. 100 patients were divided into two groups. All patients received mecobalamin dispersible tablets, ginkgo biloba leaves and Flunarizine hydrochloride capsules. However, patients in the experimental group needed to receive postauricular methylprednisolone injection, and patients in the control group received postauricular ligustrazine hydrochloride injection. Compare the effectiveness of treatment between two groups of patients. Result: After treatment, the total effective rate of the experimental group was 95%, while the total effective rate of the control group was 62%. The difference in total effective rate between the two groups was statistically significant (P<0.05). Conclusion: Patients with acute tinnitus who receive retroauricular injection of methylprednisolone during clinical treatment can achieve significant results without any adverse reactions, and is worthy of promotion and use in future clinical treatment.